| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Mark S. Forman | Chief Medical Officer | 2025-11-17 | 3,000 | $1.03 | $3.09kBuy |
| Roy Gonzales | Senior VP Finance | 2025-11-17 | 1,767 | $1.03 | $1.82kBuy |
| Mark S. Forman | Chief Medical Officer | 2025-05-15 | 3,000 | $1.03 | $3.09kBuy |
| Roy Gonzales | Senior VP Finance | 2025-05-15 | 1,750 | $1.03 | $1.80kBuy |
| John Nuss | CHIEF SCIENTIFIC OFFICER | 2025-04-02 | 1,887 | $1.07 | $2.02kSell |
| John Nuss | CHIEF SCIENTIFIC OFFICER | 2024-12-27 | 21,119 | $2.36 | $49.84kSell |
| Sheila Gujrathi | Director | 2024-12-23 | 130,000 | $2.31 | $300.56kBuy |
| John Nuss | CHIEF SCIENTIFIC OFFICER | 2024-12-19 | 13,161 | $2.26 | $29.68kSell |
| John Nuss | CHIEF SCIENTIFIC OFFICER | 2024-12-10 | 5,377 | $0.20 | $1.08kBuy |
| John Nuss | CHIEF SCIENTIFIC OFFICER | 2024-12-10 | 193,557 | $0.20 | $38.71kBuy |
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Nsv Partners III LP | 33.77% | 24,099,470 | $210.15M | Insider |
| Nsv Investments I LP | 23.67% | 16,892,528 | $147.30M | Insider |
| Somu Subramaniam | 17.48% | 12,471,848 | $108.75M | Insider |
| Venbio Global Strategic Fund III LP | 7.02% | 5,011,536 | $43.70M | Insider |
| Affinity Asset Advisors LLC | 5.50% | 3,924,415 | $34.22M | Institution |
| Vanguard Group Inc | 5.28% | 3,769,997 | $32.87M | Institution |
| Point72 Asset Management LP | 4.50% | 3,209,645 | $27.99M | Institution |
| Tang Capital Management LLC | 4.34% | 3,100,000 | $27.03M | Institution |
| Marshall Wace LLP | 3.25% | 2,316,275 | $20.20M | Institution |
| Raju Mohan | 3.23% | 2,303,540 | $20.09M | Insider |